Next 10 |
2024-04-09 09:28:17 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Harvard Bioscience Historical ear...
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of appro...
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both t...
2024-03-07 12:53:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Harvard Bioscience (NASDAQ: HBIO ) just reported results for the fourth quarter of 2023. Harvard Bioscience reported earnings per share of 4 cents. This was below the anal...
2024-03-07 09:56:04 ET Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Conference Call March 07, 2024, 08:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President & Chief Executive Officer Jennifer Cote - Chief Fina...
2024-03-07 07:02:45 ET More on Harvard Bioscience Seeking Alpha’s Quant Rating on Harvard Bioscience Historical earnings data for Harvard Bioscience Financial information for Harvard Bioscience Read the full article on Seeking Alpha For further...
Q4 Revenues of $28.2 million Q4 Gross Margin of 58.0% (230 bps year-over-year improvement) Q4 operating income of $0.3 million, adjusted operating income of $ 3.3 million Strong operating cash ...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
2024-03-06 10:56:37 ET More on Harvard Bioscience Seeking Alpha’s Quant Rating on Harvard Bioscience Historical earnings data for Harvard Bioscience Financial information for Harvard Bioscience Read the full article on Seeking Alpha For further...
HOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology (SOT) conference from March 11-13, 2024, in Salt Lake City. Complementing an already extensive produc...
News, Short Squeeze, Breakout and More Instantly...
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of appro...
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both t...